Heron Therapeutics (HRTX) CAPEX/Revenue US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
CAPEX/Revenue, % 4.90% 7.69% 3.50% 1.69% 1.22%   0.90%  
Changes by years, y/y, % -7pp +3pp -4pp -2pp 0pp     -36.6%

Heron Therapeutics. CAPEX/Revenue, %

Heron Therapeutics. CAPEX/Revenue, changes, pp

Heron Therapeutics (HRTX) CAPEX/Revenue US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
CAPEX/Revenue, % 2.52% 0.73% 0.00% 1.77% 1.02%   0.90%
Changes by years, y/y, % +2pp -1pp -1pp +1pp -2pp    
Changes by quarters, q/q, % +2pp -2pp -1pp -1pp    

Heron Therapeutics. CAPEX/Revenue, %

Heron Therapeutics. CAPEX/Revenue, changes, pp

Heron Therapeutics. CAPEX/Revenue, changes, pp